Combinatory Treatment with miR-7-5p and Drug-Loaded Cubosomes Effectively Impairs Cancer Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combinatory Treatment with miR-7-5p and Drug-Loaded Cubosomes Effectively Impairs Cancer Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 14, Pages 5039
Publisher
MDPI AG
Online
2020-07-17
DOI
10.3390/ijms21145039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells
- (2020) Zdravka Medarova et al. Scientific Reports
- miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
- (2020) Carmen Elena Condrat et al. Cells
- The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme
- (2020) Anna Kirstein et al. Cancers
- The role and mechanisms of action of microRNAs in cancer drug resistance
- (2019) Wengong Si et al. Clinical Epigenetics
- MIX2: A Novel Natural Multi-Component Modulator of Multidrug-Resistance and Hallmarks of Cancer Cells
- (2019) Agata M. Gawel et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
- (2019) Melina Arnold et al. LANCET ONCOLOGY
- MicroRNA delivery through nanoparticles
- (2019) Sharon Wei Ling Lee et al. JOURNAL OF CONTROLLED RELEASE
- Fusion dynamics of cubosome nanocarriers with model cell membranes
- (2019) Brendan P. Dyett et al. Nature Communications
- Enhanced Chemotherapeutic Efficacy of Paclitaxel Nanoparticles Co-delivered with MicroRNA-7 by Inhibiting Paclitaxel-Induced EGFR/ERK pathway Activation for Ovarian Cancer Therapy
- (2018) Xiaojuan Cui et al. ACS Applied Materials & Interfaces
- Cubosomes; the next generation of smart lipid nanoparticles?
- (2018) Hanna Maria Gabriella Barriga et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ ABCC1 axis
- (2018) Huiqin Hu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-7-5p overexpression suppresses cell proliferation and promotes apoptosis through inhibiting the ability of DNA damage repair of PARP-1 and BRCA1 in TK6 cells exposed to hydroquinone
- (2018) Hao Luo et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Electrochemical and biological characterization of lyotropic liquid crystalline phases – retardation of drug release from hexagonal mesophases
- (2018) Ewa Nazaruk et al. JOURNAL OF ELECTROANALYTICAL CHEMISTRY
- Current Challenges and Opportunities in Treating Glioblastoma
- (2018) Andrea Shergalis et al. PHARMACOLOGICAL REVIEWS
- A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
- (2018) Xiaoyue Chen et al. Nature Communications
- miR‑7‑5p inhibits cell migration and invasion in glioblastoma through targeting SATB1
- (2018) Chang‑You Yin et al. Oncology Letters
- MiR-7-5p suppresses stemness and enhances temozolomide sensitivity of drug-resistant glioblastoma cells by targeting Yin Yang 1
- (2018) Bo Jia et al. EXPERIMENTAL CELL RESEARCH
- Voltammetric and biological studies of folate-targeted non-lamellar lipid mesophases
- (2018) Marlena Godlewska et al. ELECTROCHIMICA ACTA
- MicroRNA-7-5p regulates the proliferation and migration of intestinal epithelial cells by targeting trefoil factor 3 via inhibiting the phosphoinositide 3-kinase/Akt signalling pathway
- (2017) Jing Guo et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Lipidic Cubic-Phase Nanoparticles-Cubosomes for Efficient Drug Delivery to Cancer Cells
- (2017) Ewa Nazaruk et al. ChemPlusChem
- RNAi-combined nano-chemotherapeutics to tackle resistant tumors
- (2016) Rakesh Kumar Tekade et al. DRUG DISCOVERY TODAY
- Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line
- (2016) Angui Li et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression
- (2016) Yong-tao Gao et al. Scientific Reports
- miR-7-5p suppresses cell proliferation and induces apoptosis of breast cancer cells mainly by targeting REGγ
- (2015) Yuan Shi et al. CANCER LETTERS
- MicroRNA-7: A miRNA with expanding roles in development and disease
- (2015) Jessica L. Horsham et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review)
- (2015) GIULIO CABRINI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma
- (2015) Pedro M. Costa et al. JOURNAL OF CONTROLLED RELEASE
- Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells
- (2015) Alessandro Bertucci et al. Small
- A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas
- (2015) Deepa Kushwaha et al. Oncotarget
- MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma
- (2014) Rainer Tuominen et al. INTERNATIONAL JOURNAL OF CANCER
- Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances
- (2014) Nishant S. Gandhi et al. JOURNAL OF CONTROLLED RELEASE
- MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1
- (2014) Zhiguo Liu et al. TUMOR BIOLOGY
- Cubic and Hexagonal Liquid Crystals as Drug Delivery Systems
- (2014) Yulin Chen et al. Biomed Research International
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo
- (2013) Huan Meng et al. ACS Nano
- MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1
- (2013) Wenxing Qin et al. FEBS LETTERS
- miRNA-7-5p inhibits melanoma cell migration and invasion
- (2012) Keith M. Giles et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis
- (2012) N Zhang et al. ONCOGENE
- Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat
- (2011) Du Cheng et al. BIOMATERIALS
- Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA
- (2011) Oleh Taratula et al. JOURNAL OF DRUG TARGETING
- Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line
- (2010) Huan Meng et al. ACS Nano
- Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics
- (2010) K. E. Allen et al. MOLECULAR CANCER THERAPEUTICS
- Aberrant MicroRNA-155 Expression Is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma
- (2010) Ji Kon Ryu et al. PANCREATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started